| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
RDNT sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.21M | $76.88M | - | |
| CEO | 507.2K | $29.73M | - | |
| COO | 261.2K | - | - | |
| VP | 200.2K | - | - | |
| Dir | 177.0K | $9.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 25, 2018 | Hames Norman R56 | President, Western Operations | Sell | 15,000 | $12.77 | $191,550.00 | -4.4% | |
| May 18, 2018 | Hames Norman R56 | President, Western Operations | Sell | 15,000 | $13.04 | $195,645.00 | -4.3% | |
| May 11, 2018 | Crues John V | Medical Director | Sell | 15,000 | $13.00 | $195,070.50 | -2.8% | |
| Mar 20, 2018 | Stolper Mark | Executive VP And CFO | Sell | 15,000 | $13.19 | $197,850.00 | -10.3% | |
| Mar 16, 2018 | Hames Norman R56 | Executive Vice President | Sell | 40,000 | $12.95 | $517,900.00 | -10.2% | |
| Mar 14, 2018 | Linden Jeffrey L | Executive Vice President | Sell | 10,000 | $13.09 | $130,900.00 | -1.1% | |
| Mar 14, 2018 | Murdock Michael N45 | Executive Vice President | Sell | 38,333 | $13.06 | $500,628.98 | -26.3% | |
| Mar 13, 2018 | Cadwell Marvin S | Director | Sell | 35,594 | $12.58 | $447,772.52 | -11.8% | |
| Dec 20, 2017 | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $9.96 | $49,780.00 | -1.4% | |
| Dec 19, 2017 | Crues John V | Medical Director | Sell | 19,684 | $10.01 | $196,962.04 | -3.5% |